Oncologic outcomes of radical radiotherapy in frail patients with upper tract urothelial carcinoma.

Authors

Willy Po-Yuan Chen, Wing-Keen Yap, Hao-Lun Luo, Yao-Yu Wu, Miao-Fen Chen, Shih-Ming Huang, Din-Li Tsan, Po-Hung Lin, Kai-Jie Yu, Yu-Hsiang Lin, I-Hung Shao, Hung-Cheng Kan, Po-Jung Su, Wen-Kuan Huang, Po-Jui Chen, Po-Ying Peng

Published in

BJU international. Jul 31, 2026. Epub Jul 31, 2026.

Abstract

To evaluate oncologic outcomes of high-dose radical radiotherapy (RT) in medically frail patients with upper tract urothelial carcinoma (UTUC).
We retrospectively reviewed 63 patients with UTUC who received definitive RT at four major academic hospitals (2014-2021) with significant comorbidities (age-adjusted Charlson Comorbidity Index ≥3). Patients were stratified into high- and low-dose groups using a biologically effective dose (BED₁₀) cutoff of 74.3 Gy (from 63 Gy/35 fractions, assuming α/β ratio = 10). The median BED₁₀ was 64.8 Gy (interquartile range 60.0-72.0) in the low-dose group and 84.0 Gy (interquartile range 78.4-86.4) in the high-dose group. Baseline imbalances were addressed using inverse probability of treatment-weighted (IPTW) in Cox proportional hazard models and Kaplan-Meier analyses.
The median follow-up was 76 months. The pelvic ureter was the most frequently involved site (57%), followed by the renal pelvis (33%) and the abdominal ureter (21%). In the IPTW-adjusted cohort, the disease control rate was significantly higher with high-dose RT (98% vs 62%, P < 0.001). High-dose RT significantly improved IPTW-adjusted locoregional control (3-year LRC: 51% vs 29%, P = 0.041), freedom from distant metastasis (3-year FFDM: 75% vs 39%, P = 0.001), freedom from progression (3-year FFP: 43% vs 25%, P = 0.013), and overall survival (3-year OS: 46% vs 11%, P < 0.001). Multivariate analysis identified higher RT dose as an independent prognosticator of improved FFP (adjusted hazard ratio [aHR] 0.96, P = 0.018) and OS (aHR 0.93, P < 0.001). Furthermore, pre-RT gross haematuria (aHR 2.63, P = 0.002) and age-adjusted Charlson Comorbidity Index >5 (aHR 2.85, P = 0.007) were associated with worse OS.
A clear dose-response relationship was observed in UTUC treated with definitive RT. High-dose RT was associated with significantly improved survival and represents a safe alternative for medically frail patients.

PMID:
42533861
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.